FDA Action Alert: Merck, Verona, AbbVie and Rocket
Pictured: A scientist with pill bottles in front of FDA headquarters/Taylor Tieden for BioSpace To close out the month, the FDA will hand down decisions on four treatments, including one for an antibody-drug conjugate in lung cancer and another for a …